KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomePension (IS)Profit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Adient (ADNT) Shares Outstanding (Weighted Average) (2016 - 2025)

Adient's Shares Outstanding (Weighted Average) history spans 11 years, with the latest figure at $78.7 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) fell 6.75% year-over-year to $78.7 million, compared with a TTM value of $78.7 million through Dec 2025, down 6.75%, and an annual FY2025 reading of $83.0 million, down 7.26% over the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $78.7 million at Adient, down from $83.0 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $95.2 million in Q1 2023, with the low at $78.7 million in Q4 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $90.8 million, with a median of $94.1 million recorded in 2021.
  • Year-over-year, Shares Outstanding (Weighted Average) increased 0.64% in 2021 and then fell 9.15% in 2024.
  • Tracing ADNT's Shares Outstanding (Weighted Average) over 5 years: stood at $94.6 million in 2021, then grew by 0.53% to $95.1 million in 2022, then decreased by 2.31% to $92.9 million in 2023, then dropped by 9.15% to $84.4 million in 2024, then dropped by 6.75% to $78.7 million in 2025.
  • Per Business Quant, the three most recent readings for ADNT's Shares Outstanding (Weighted Average) are $78.7 million (Q4 2025), $83.0 million (Q3 2025), and $83.9 million (Q2 2025).